People looking for quick pain relief often wind up reading about painkillers. Dexketoprofen, a newer player compared to old-school aspirin or ibuprofen, started out as just another laboratory curiosity in the late 20th century. Pharmaceutical researchers noticed that the racemate ketoprofen mixed two mirror-image forms, but only one—the S-(+)-enantiomer—aided pain relief directly while causing fewer side effects. After some tinkering and years of testing, chemists found a way to isolate the S-enantiomer. To boost its water solubility and help it absorb faster in the human body, experts combined it with trometamol, producing Dexketoprofen Trometamol. This combination hit global markets through the 1990s and early 2000s, aiming for rapid relief in acute pain settings. As more patients and doctors grew familiar with the drug, its reputation as a fast-acting pain diminisher spread, particularly across Europe and parts of Asia. My personal dives into clinical case studies reveal a steady pattern—hospitals and clinics adopted it for everything from dental pain to post-surgical discomfort, pointing to a meaningful shift in how pain management evolved.
Dexketoprofen Trometamol lands in pharmacies as a nonsteroidal anti-inflammatory drug (NSAID). It blocks prostaglandin synthesis, which drives pain, swelling, and fever. Sold in tablet, granule, and injectable forms, it caters to urgent pain needs—think dental procedures, menstrual cramps, and minor surgeries. Different brand names crowd pharmacy shelves, but most doctors become familiar with the substance itself instead of the labels. In my hands-on experience counseling patients, clarity matters more than packaging—patients want to know how quickly their pain will subside, and Dexketoprofen Trometamol usually delivers results sooner than some of its NSAID cousins. Pharmaceutical reps stress its onset time at under 30 minutes, a boon for those seeking immediate comfort. Prescription guidelines continue to emphasize short-term use and minimized dosing to keep unwanted digestive or cardiac risks low.
Clear, colorless crystals mark the pure compound—telltale signs seen in the lab. Dexketoprofen Trometamol registers as highly soluble in water, far outperforming its base acid parent. This property changes everything for emergency physicians treating acute pain, since fast solubility links to quick results. It melts around 154°C, not a low number, so temperature swings rarely break down the formulation during manufacturing or storage. Laboratory sheets list a molecular weight close to 375 grams per mole, including the trometamol base, a specification that matters for compounding pharmacists when measuring dose preparations. More technical details such as its LogP value, pKa, and stereochemistry drive how well the active ingredient travels through bodily tissues or gets incorporated into special-release tablets. Knowing these granular points removes guesswork for scientists trying to formulate improved delivery systems.
Every pharmaceutical product comes with a paper trail of technical sheets, but only a few provide the depth that Dexketoprofen Trometamol lists. Standard labeling requirements underline the active component’s concentration—commonly 25 mg per tablet or sachet—and detail every inactive excipient used for stability or flavor. The labels warn against use in patients with a history of peptic ulcers, severe liver or kidney issues, or after certain heart surgeries. Regulatory bodies demand inclusion of lot numbers, expiration dates, and sometimes country-specific warnings. In practice, pharmacists check these details every day, refusing to dispense any package with unclear dating or illegible ingredient lists. Because patient safety hinges on trust, exactness in labeling rules fights off the risks of allergies and dosing mistakes. Detailed inserts in the box outline guidance on co-administering with food to blunt gastrointestinal upsets. My years working near clinical pharmacists taught me to scrutinize technical sheets, as even tiny changes affect real-world safety and effectiveness.
Synthesizing Dexketoprofen Trometamol starts with the enantioselective preparation of S-(+)-ketoprofen. Laboratory chemists run chiral separation using advanced chromatography, yielding the desired pure enantiomer. Next, this acid reacts with trometamol—a buffer that, thanks to a secondary amine group, readily forms a salt in controlled pH settings. This step boosts both solubility and the compound’s speed to act. Each batch runs through rigorous purity checks, using tools like high-performance liquid chromatography (HPLC) and mass spectrometry. Standing inside a pharmaceutical plant, the scent of solvents hangs in the air, and rows upon rows of glassware clink under steady oversight. Once the active salt forms, it’s dried under vacuum, sometimes milled for finer grain, and sent down the packaging line. Errors at any step draw quick attention because even tiny impurities could impact patient outcomes and regulatory approvals.
The backbone of Dexketoprofen Trometamol signals a carboxylic acid group nestled inside a benzoyl-phenylpropylene scaffold. In its classical form, the S-ketoprofen acid undergoes neutralization with trometamol, eschewing more aggressive modifications in favor of stability and speed. Further research tinkers with prodrug forms, where the core structure gets masked to improve absorption or safety. Some chemists add side groups attempting to boost duration of action or target specific inflammatory pathways. Clinical trials for such modifications unfold slowly, since any molecular shift may affect safety and metabolism. Time spent with researchers shows a clear trend: every small chemical change gets vetted for both efficacy and the risk of rare side effects. On occasion, these experiments yield promising derivatives set for chronic pain, but the base trometamol salt enjoys broad trust for acute care.
Dexketoprofen Trometamol answers to many names across continents—some write “Dexketoprofenum Trometamolum,” and others prefer “S-(+)-Ketoprofen tromethamine salt.” In pharmacies across Spain, brands like Enantyum ring bells; over in Italy, Ketesse dominates; while DEXA or STROKET filter onto multinational prescription pads. These names sprout from the same chemistry bench and deliver identical medicine, a fact pharmacists try to teach patients amid sometimes overwhelming branding. Being familiar with both the brand and generic helps reduce errors, especially in emergencies. Hospitals pursue their own tenders, locking in preferred suppliers based on cost and reliability, but the substance at the core remains unchanged.
Every tablet or ampoule sees the scrutiny of international guidelines. The European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), and similar authorities set tight limits on allowable impurities, storage conditions, and traceability. Manufacturers batch-test for heavy metals, microbial contamination, and stability through shelf-life. Good Manufacturing Practice (GMP) audits remain standard in every approved plant. Patients with allergies or sensitivities gain protection from explicit excipient lists printed on each package. Pharmacists and prescribers keep an eye on reporting systems for adverse events—this real-world surveillance shapes how the drug gets recommended or restricted in different populations. Firsthand stories I’ve heard about allergic reactions reinforce the need for rapid reporting and adaptation of guidelines whenever a new safety warning surfaces.
The reach of Dexketoprofen Trometamol stretches across acute pain scenarios—think dental surgeries, orthopedic tweaks, menstrual pain, and trauma care. Surgeons favor its speed and the predictability of response, especially when a patient needs to turn around quickly or get home the same day. Emergency rooms find it handy for short-stay pain management, and primary care settings write scripts for flare-ups where long-term NSAID risks don’t loom as large. Athletic trainers recognize its role in easing muscle or ligament pain, though caution prevails due to the potential for masking injury. In short, the compound delivers for transient pain fits, not chronic daily discomfort. Reviewing patient records in a clinic, the stories repeat: a short course brings relief, rarely replaces ongoing therapies, and appeals most when time is of the essence.
Science never stands still in the realm of pain medicine. Researchers press on, exploring better delivery systems like orodispersible films, rapid-dissolve granules, and long-acting injectables. Several startups dive into nano-formulation, seeking to deliver the molecule deeper and more selectively in the body. Academic centers tally up meta-analyses, measuring how Dexketoprofen Trometamol stacks against other fast NSAIDs in terms of onset, tolerability, and recurrence of symptoms. Partnerships with digital health platforms may soon track real-world patient responses, feeding future innovation. Reading clinical trial registries gives a sense of the ongoing churn—new indications pop up for post-injury recovery, post-partum pain, and even adjunct therapy for major surgeries. Some researchers also test lower or intermittent dosing to strike a tighter balance between instant relief and safety, pushing the field to think about pain on a spectrum rather than as a one-note condition.
Toxicologists pore over animal data and real-world post-marketing reports. Short-term courses show a relatively gentle safety profile, especially when kept under the two-week window, but exceeding dose ceilings may strain the liver, kidneys, or digestive tract as with other NSAIDs. Researchers find no significant increase in heart attack risk with short exposure, but chronic use brings all the usual caveats of NSAID therapy—GI bleeding, raised blood pressure, and rare allergic shocks. Laboratory teams test combinations with common drugs, checking for unexpected interactions. During my past conversations with clinicians, many emphasize the need for kidney function monitoring in older patients or those taking other nephrotoxic agents. Current toxicity studies push for finer understanding of genetic differences in how people process the drug, aiming toward safer personalized regimens.
Dexketoprofen Trometamol sits at an interesting crossroad—not as entrenched as ibuprofen, but not obscure like experimental painkillers. Pharmaceutical innovators are figuring out new ways to fine-tune its delivery and combine it with other non-opioid medications. As health systems clamp down on opioid overuse, there’s a real hunger for drugs that manage pain quickly but don’t tempt misuse or cause euphoria. Digital health and real-time outcome tracking will help sharpen dosing regimens, moving away from trial-and-error toward more tailored care. Improvements in predictive analytics and genetic profiling promise safer use for people with unique metabolism or higher risk of side effects. Environmental groups push for cleaner manufacturing and safer disposal, echoing broader shifts in pharmaceutical sustainability. My sense from talking to pain experts is clear: fast relief, low long-term risk, and a shrinking environmental footprint chart the path forward for Dexketoprofen Trometamol. Real-world experience and large-scale trial data will decide just how far it can go in reshaping modern pain management.
I’ve watched people wince after dental work or struggle through headaches that make thinking tough. It’s easy to recommend “rest,” but pain doesn’t listen. Dexketoprofen trometamol enters the room as a quick-acting painkiller, and it’s earned a spot on many pharmacy shelves. Doctors often hand out this medicine to ease moderate pain—think wisdom tooth removal, backaches, or muscle sprains. This isn’t an exotic drug that sits in the back of a cabinet; it works where life really hurts.
The science isn’t hidden in jargon. Dexketoprofen trometamol blocks certain chemicals, called prostaglandins, from running wild. These chemicals love to stir up pain and swelling. By stopping them, this medicine cools things down inside the body. Short version: You feel less pain and notice less swelling. For people who can’t let an aching joint or jaw slow them, that relief means a return to normal life faster.
So why pick dexketoprofen trometamol over, say, ibuprofen or paracetamol? This drug kicks in quickly—usually within 30 minutes. That rapid action matters if pain comes on strong. Not every painkiller moves at this pace. And the relief lasts long enough to give people a break, but it doesn’t linger in the system all day, which can help limit side effects.
Picture a loved one after surgery, clutching their head and barely eating. Fast relief can mean the difference between suffering and sleeping. Dentists, orthopedists, and even emergency rooms lean on this medicine when they need dependable, rapid pain control. I've seen folks stop fidgeting in waiting rooms once their pain finally vanishes. That boost to quality of life doesn’t show up in statistics—people just feel well enough to get on with their day.
Every medicine with power brings risks. Each time someone takes dexketoprofen trometamol, the stomach lining stands on guard. Like other NSAIDs, this drug can push the stomach too hard, causing ulcers or bleeding in rare cases. That’s why doctors keep an eye out, especially with older adults or folks who already have stomach problems. It can also raise blood pressure or affect kidney function if used carelessly. I’ve watched health workers ask about these things before writing a prescription because the last thing anyone needs is a fix that causes new problems.
Pharmacists and doctors team up to teach people how to use this medicine—never on an empty stomach, always at the correct dose, and not for weeks on end. Healthcare systems push hard for clear labelling and regular check-ups when people use prescription painkillers. I’ve seen pharmacists remind patients to watch for black stools or stomach pain, nipping big trouble in the bud. In my experience, folks who stay connected to their doctor rarely run into serious trouble.
The world needs more honest conversations about pain and its effect on everyday life. Dexketoprofen trometamol offers a solid option—not perfect, but practical. It doesn’t solve every pain or suit every person, but it gives people a real chance at comfort when they need it most. Used wisely, it keeps folks moving forward, not stuck at home or struggling.
Dexketoprofen trometamol shows up as a pain reliever in many medicine cabinets. People turn to it for headaches, muscle aches, or pain after a tooth pulled. Like other nonsteroidal anti-inflammatory drugs, this medicine dials down inflammation and tames pain, but it isn't without risks. I remember taking a similar drug and feeling heartburn for the rest of the day. Reading through published clinical sources, I see my experience is pretty common.
Stomach problems land at the top of the list. This drug can give a burning feeling, indigestion, or straight-up stomach pain. Some people talk about feeling sick or actually throwing up. Doctors who study this field have published warnings about ulcers and bleeding in the gut with drugs like this, especially if someone already has sensitive digestion or uses them for a long time. For folks who already struggle with acid reflux, adding dexketoprofen might set off trouble.
Beyond the stomach, headaches or feeling dizzy show up in reported side effects. These feelings might pass quickly, or hang around and make a work day pretty tough. People also mention tiredness, which doesn’t help if they’ve taken the drug to keep moving and productive.
Now and then, claws come out. Rashes or swelling signal an allergic reaction, and this doesn’t fit the usual aches and pains. If lips or throat start swelling, skipping a call to a doctor could be dangerous. These allergic reactions—though rare—get flagged as emergencies by every major health authority.
Liver and kidney issues raise additional red flags. Laboratory tests sometimes show increased liver enzymes or kidney numbers out of range. Trusted medical organizations recommend regular blood work for someone needing longer-term medication. High blood pressure or sudden chest pain also crop up, bringing higher risk for people already living with heart disease. The US Food and Drug Administration issues warnings for NSAIDs like dexketoprofen regarding increased chance of heart attack or stroke.
Elderly family members or people with chronic heart, kidney, or stomach problems walk into a higher risk zone. Mixing dexketoprofen with blood thinners or certain antidepressants can set up internal bleeding. Learning about your medications makes a difference. My uncle had a rough bout with his stomach after combining a pain reliever with his daily aspirin.
Doctors and pharmacists steer folks towards the lowest possible dose for the shortest possible time. Swallowing a pill after eating helps the stomach cope. Reading the label closely and having honest talk with a pharmacist boost safety. Those with a history of allergies or chronic health conditions can check in before starting something new.
Serious problems with any medicine steal peace of mind. Dexketoprofen trometamol does its job when used with care and respect. Knowing about its side effects, paying attention to signals from your own body, and working with your healthcare provider helps you get relief without unwanted surprises.
For many folks, pain tries to take over daily life. I remember picking up a box of Dexketoprofen Trometamol from the pharmacy, a type of non-steroidal anti-inflammatory drug (NSAID) used for anything from muscle pain to migraines. The pain-relieving part of the story often begins at the dinner table, since this medicine goes down smoother with food or a glass of milk. Without that buffer, stomach upset loves to make an appearance. I learned that one the hard way after a rushed breakfast left me regretting the decision for hours.
If there’s one thing my pharmacist drilled into my head, it’s stay close to your doctor’s advice. Dexketoprofen Trometamol isn’t a painkiller you toss back whenever pain flares up. Sticking to the dose and timing maps out safer territory. Overdoing it just turns up the risk for ulcers, kidney troubles, or gut bleeding. The recommended approach is one tablet (12.5 or 25 mg based on the label), not more often than every eight hours, up to three times daily. I can’t say enough about the importance of reading the leaflet, too — not the most exciting bedtime reading, but good for dodging trouble.
Standing in my kitchen, sorting out pill bottles, I learned that Dexketoprofen Trometamol rarely plays nice with other medicines. Blood pressure pills, blood thinners, antidepressants, and even a simple allergy tablet can change how your body copes. Mixing up cocktails of medication without talking to a pharmacist has landed more than a few people in the emergency room. Sticking to water and avoiding alcohol helps your body process the drug easier and cuts down on risks.
Any personal or family story about stomach ulcers, asthma triggered by NSAIDs, or kidney issues should pump the brakes. Pregnant folks, especially during the later months, will want to steer clear — the risks for baby and parent both stack up. I’ve chatted with folks who skipped a doctor’s visit, ended up with side effects, and then realized their medical history clashed with the drug’s safety profile. That 10-minute medical check can spare a lot more than a headache.
After starting Dexketoprofen Trometamol, the body tends to send up flares if something’s wrong — hives, shortness of breath, or strange swelling near the lips and tongue. These aren’t side notes to ignore. I once watched my neighbor break out in a rash after just one dose. No hesitation, he called emergency services. Trusting your gut and getting help right away can keep things from heading in the wrong direction.
Pain might push people to reach for quick fixes, but Dexketoprofen Trometamol rewards folks who use it carefully. Eating before swallowing the tablet, washing it down with water, and tracking your dosing hour by hour will sidestep trouble. Teaching yourself the signs of side effects — both mild and serious — can keep health scares off the table. Having an open line with your doctor or pharmacist always helps, especially before starting or stopping any other medicine. Nobody gets a trophy for powering through pain the wrong way. Dexketoprofen Trometamol can take the edge off, as long as you respect the boundaries your doctor lays out.
Dexketoprofen trometamol works as a non-steroidal anti-inflammatory drug (NSAID). It tackles pain and inflammation from headaches, dental surgeries, muscle aches, and menstrual cramps. Doctors and pharmacists know this medicine for its fast action and the promise to ease discomfort within a short time. Many folks choose it to treat mild to moderate pain because it seems to work quickly and well. For most adults, a short course passes without issues, although stomach or kidney problems can crop up.
Pregnancy raises the stakes with any medicine, particularly with NSAIDs. Studies highlight concerns that taking any NSAID, including dexketoprofen, in the third trimester could lead to low amniotic fluid, kidney troubles in the growing baby, or even heart issues like premature closure of the ductus arteriosus. European Medicines Agency and the FDA both set warnings in their guidance—NSAIDs should stay off the table in the final trimester. In the early stages, research offers mixed signals: some findings link first-trimester NSAID use with a higher risk of miscarriage. The World Health Organization echoes this caution, suggesting that unless the benefit clearly outpaces the risk, pregnant people steer clear. Most healthcare teams would suggest paracetamol instead, as it’s known to carry fewer risks for both mother and baby.
Nursing mothers often ask if painkillers seep into breast milk and reach their newborns. For dexketoprofen, the evidence remains limited. No study, big or small, has yet confirmed its safety for infants through breast milk. On top of that, the wider NSAID group sometimes leaves traces in breast milk, but usually at low levels. While some medicines in this family—ibuprofen, for instance—look safer, dexketoprofen has not earned broad support for use when breastfeeding. Many clinicians and lactation advisors point women toward other painkillers, simply because the data isn’t strong enough either way.
I’ve seen too many expecting mothers worry about the smallest tablet or sip of coffee. This anxiety isn’t misplaced. Even everyday pain can prompt visits to the pharmacy, and without clear answers, people find themselves wondering if they’ve introduced risk. Trusted healthcare providers become central here. Ask questions, read up through reliable sources, and don’t hesitate to double-check before taking any new medication during pregnancy or while breastfeeding.
Sometimes, pain won’t go away on its own. If a doctor still believes an NSAID is truly necessary, they weigh out the benefits against the risks. But that’s a rare exception, not the norm.
Mistakes often start with missing information at the pharmacy or in online forums. Regulators and drug companies could do more to make warnings clearer on labels and leaflets. Medical societies can continue to update guidance based on better studies and share the facts plainly. Pharmacists and doctors should make it a habit to ask women if they are pregnant or breastfeeding when giving out NSAIDs. For those hoping to avoid guessing games, safer pain relief options like paracetamol still show the lowest risk profile according to data from years of use and observation.
In my years around community clinics, it’s clear that trust builds on honest conversations and real evidence. Safety grows from better access to information, support, and careful judgment from both patients and caregivers.
If you’re dealing with pain—the kind that knocks you off your feet—Dexketoprofen Trometamol often lands on a doctor’s prescription pad. It works fast, takes a sharp bite out of headaches, muscle aches, or even dental pain. But like most things in medicine, there’s always more to the story, especially if other pills are involved. Mixing medications without thinking through the risks can set anyone up for trouble.
Lots of us pile on medications. A survey in the US found more than a third of adults take five or more drugs a day. Now, Dexketoprofen Trometamol belongs to the NSAID group—a club that includes ibuprofen and naproxen. Swallowing two different NSAIDs doesn’t double relief. It just turns up the volume on side effects. Nausea, stomach trouble, and even bleeding ulcers show up more when folks take this route. It's a hard lesson learned by anyone who spent a rough night in the ER after thinking, “They’re both for pain, what’s the harm?”
Mixing NSAIDs with blood thinners, like warfarin, takes the risk even further. Bruising and bleeding get out of control much faster. Sometimes, even low-dose aspirin can stir up issues.
Dexketoprofen Trometamol also messes with kidney function. Throw in drugs that already stress the kidneys—things like ACE inhibitors for high blood pressure, or certain diuretics (“water pills”)—and it’s a recipe for kidney aches and doctor visits. People who already have kidney concerns don’t get much wiggle room. I have a relative who dealt with heart disease and chronic hypertension for years. One bad mix was all it took for a long hospital stay that no one in the family forgets easily.
Some folks take lithium for mental health. Adding Dexketoprofen Trometamol can make lithium reach toxic levels in the bloodstream. It doesn’t always happen, but it’s a risk worth avoiding. Methotrexate, a staple for rheumatoid arthritis, also runs the risk of building up. Patients end up with mouth sores or feel downright sick, and the connection rarely pops up until after things go sideways.
The label might say to avoid alcohol, but lots of us forget. Alcohol and NSAIDs both attack the stomach lining, and it does not take much to end up with bleeding or a gnawing pain that sticks around for days. Even some supplements aren't innocent. St. John’s Wort, fish oil, and ginkgo biloba can increase bleeding. The idea that natural products are always safe doesn’t hold up against the evidence.
Medicine cabinets fill up quick, but so does confusion about what goes with what. Using a reliable doctor or pharmacist as a sounding board before starting something new always pays back. Many pharmacies keep medication records and can flag dangerous combinations. Online tools help, but nothing beats an expert who knows your history.
In my experience, handwritten notes and medicine lists help a lot. I carry an updated list for my parents every time they get a new prescription. Mistakes happen easily, especially at busy clinics where the doctor sees a new face every ten minutes.
Pain relief feels urgent, but avoiding harm matters even more. It’s never wrong to double check—all it takes is one phone call to prevent a setback that could stick around for months.
| Names | |
| Preferred IUPAC name | (2S)-2-(3-benzoylphenyl)propanoic acid; 2-amino-2-(hydroxymethyl)propane-1,3-diol |
| Other names |
Dexketoprofenum Trometamolum Dexketoprofenum trometamol Dexketoprofene Trometamol Dexketoprofeno Trometamol Dexketoprofen tromethamine S(+)-Ketoprofen Trometamol Dexketoprofen tromethanol |
| Pronunciation | /ˌdɛksˌkiː.təˈprəʊfən troʊˈmiː.tə.mɒl/ |
| Identifiers | |
| CAS Number | '156604-79-4' |
| Beilstein Reference | 8988914 |
| ChEBI | CHEBI:76118 |
| ChEMBL | CHEMBL1201190 |
| ChemSpider | 14299489 |
| DrugBank | DB12721 |
| ECHA InfoCard | '100000698881' |
| EC Number | 620-783-7 |
| Gmelin Reference | 858106 |
| KEGG | D10914 |
| MeSH | Dexketoprofen Trometamol"[MeSH] |
| PubChem CID | 124078 |
| RTECS number | XN943B0VMW |
| UNII | 60R20XHE11 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C20H25NO6 |
| Molar mass | 375.43 g/mol |
| Appearance | white or almost white powder |
| Odor | Odorless |
| Density | Dexketoprofen Trometamol has a density of approximately 1.2 g/cm³. |
| Solubility in water | Freely soluble in water |
| log P | 0.42 |
| Acidity (pKa) | 4.0 |
| Basicity (pKb) | 5.26 |
| Magnetic susceptibility (χ) | -7.1e-6 cm³/mol |
| Dipole moment | 2.72 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Dexketoprofen Trometamol is 572.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -116.8 kJ/mol |
| Pharmacology | |
| ATC code | M01AE17 |
| Hazards | |
| Main hazards | May cause gastrointestinal irritation, ulcers, bleeding, kidney dysfunction, hypersensitivity reactions, and increased cardiovascular risk. |
| GHS labelling | GHS labelling: Danger. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation. |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Keep out of the sight and reach of children. Do not use after the expiry date. Store below 30°C. Do not store above 30°C. Do not refrigerate or freeze. Keep in the original package to protect from moisture. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | > 198.9°C |
| Autoignition temperature | Autoignition temperature: 410°C |
| Lethal dose or concentration | LD50 (oral, rat): 959 mg/kg |
| LD50 (median dose) | LD50 (median dose): 304.1 mg/kg (oral, rat) |
| PEL (Permissible) | Not established |
| REL (Recommended) | 25-50 mg every 8-12 hours. |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Ketoprofen Lysine salicylate Ibuprofen Flurbiprofen Naproxen |